Consequently, the present data suggest that Mzb sensitizes CDDP chemotherapy by upregulating Ang-1 expression and downregulating Flt-3L, SCF, Tie-2 and Ki-67 expression in cervical cancer xenografts. Here, MKI67 is linked to cervical cancer.